The Effects of Restricted Dietary of AGEs on the Glycemic Control, Oxidative Stress and Inflammation (AGEs)
The Effects of Restricted Dietary of Advanced Glycation End Products(AGEs) on the Glycemic Control, Oxidative Stress and Systemic-inflammation in Patients With Metabolic.
Sponsor: Dr Azita Hekmatdoost
This NA trial investigates Metabolic Syndrome and is currently completed. Dr Azita Hekmatdoost leads this study, which shows 8 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
▶ Show 3 earlier versions
-
Oct 2017 — Jun 2018 [monthly]
Completed NA
Status: Enrolling By Invitation → Completed
-
Sep 2017 — Oct 2017 [monthly]
Enrolling By Invitation NA
Status: Not Yet Recruiting → Enrolling By Invitation
-
Jul 2017 — Sep 2017 [monthly]
Not Yet Recruiting NA
First recorded
Jan 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Dr Azita Hekmatdoost
For direct contact, visit the study record on ClinicalTrials.gov .